The cloud platform will empower biotech companies and CROs with an integrated solution for clinical data management and is supported by Emmes specialist data management teams
ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment
Anand Rathi maintains long-term guidance of 10-15% revenue growth and 40% EBITDA margins
RNA extraction free kit to deliver results in just 45 minutes
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
The campaign aims to promote women’s health and wellness and urge them to visit the hospital for key medical check-ups
In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership
_256_384.jpg)
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
It is the first hospital in the country to achieve the significant milestone of completing over 2600 robotic surgeries for treating patients with prostate, kidney and urinary bladder cancer
Subscribe To Our Newsletter & Stay Updated
